Experience of using controlled prolonged hyperglycemia in patients with mechanical jaundice secondary to choledocholithiasis

Maksymenko M.V.,Havryliuk R.O.

Main
Publications
Experience of using controlled prolonged hyperglycemia in patients with mechanical jaundice secondary to choledocholithiasis

February 28, 2025

140

Surgery

Maksymenko M.V.

Havryliuk R.O.

УДК: 616.36:616.15

DOI: 10.32471/umj.1680-3051.263499

Keywords :

Specialities :

Resume

Objective: to investigate the effect of controlled prolonged hyperglycemia on the restoration of liver functions and improvement of general condition in patients with mechanical jaundice secondary to choledocholithiasis.

Materials and methods. We conducted a prospective randomized cohort study, evaluating the effect of controlled prolonged hyperglycemia on the restoration of liver functions and improvement of general condition in patients with mechanical jaundice secondary to choledocholithiasis. The study participants were randomly assigned to two groups: a controlled prolonged hyperglycemia group, where blood glucose levels were maintained at 10–12 mmol/L, and a control group.

Results. The therapeutic hyperglycemia group showed significantly faster improvement in biochemical and clinical parameters compared with the control group. During the 21-day study period, there were decreases in serum bilirubin, liver enzyme activities, and systemic inflammation markers, with the most significant differences observed during the first week of treatment.

Conclusion. Controlled prolonged hyperglycemia is a promising strategy for improving clinical and biochemical outcomes in patients with mechanical jaundice due to choledocholithiasis. However, the results of this study are preliminary and need to be confirmed by larger multicenter studies. The creation of standardized protocols and safety guidelines will be essential for the wider implementation of this approach in clinical practice.

References

1. Li S., Guizzetti L., Ma Ch. et al. (2023) Epidemiology and outcomes of choledocholithiasis and cholangitis in the United States: trends and urban-rural variations. BMC Gastroenterol., 23(1): 254. doi: 10.1186/s12876-023-02868-3.
2. Stinton L.M., Shaffer E.A. (2012) Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut and liver, 6(2): 172–187. doi: 10.5009/gnl.2012.6.2.172.
3. Tazuma S. (2006) Gallstone disease: Epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic). Best Pract. Res. Clin. Gastroenterol., 20(6): 1075–1083. doi: 10.1016/j.bpg.2006.05.009.
4. Fevery J. (2008) Bilirubin in clinical practice: a review. Liver Int., 28(5): 592–605.
5. Wang L., Wei-Feng Yu. (2014) Obstructive jaundice and perioperative management. Acta anaesthesiologica Taiwanica, 52(1): 22–29. doi: 10.1016/j.aat.2014.03.002.
6. Chen H.-L., Wu Sh.-H., Hsu Sh.-H. et al. (2018) Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases. J. Biomed. Sci., 25(1): 75.
7. Liu D., Yu Q., Li Z. et al. (2021) UGT1A1 dysfunction increases liver burden and aggravates hepatocyte damage caused by long-term bilirubin metabolism disorder. Biochem. Pharm., 190: 114592. doi: 10.1016/j.bcp.2021.114592.
8. Muriel P. (1995) High fat diet and liver damage induced by biliary obstruction in the rat. J. applied toxicol., 15(2): 125–128. doi: 10.1002/jat.2550150211.
9. Maksymenko M.V., Susak Ya.M., Korotia M.V. et al. (2024) Standards for Providing Emergency Care at the Prehospital and Early Hospital Stages for Patients With Mechanical Jaundice. Emergency Medicine, 20(2): 137–143. doi: 10.22141/2224-0586.20.2.2024.1677.
10. Modha K. (2015) Clinical Approach to Patients With Obstructive Jaundice. Techniq. Vasc. Intervent. Radiol., 18(4): 197–200. doi: 10.1053/j.tvir.2015.07.002.
11. Maksymenko M.V., Volkovetskii V.V. (2024) The Role and Designation of Emergency Choledochoscopy in the Laparoscopic Treatment of Patients With Complicated Choledocholithiasis. Emergency Medicine, 20(6): 489–496. doi: 10.22141/2224-0586.20.6.2024.1761.
12. Turina M., Fry D.E., Polk H.C. (2005) Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit. Care Med., 33(7): 1624–1633.